When is subcutaneous unfractionated or low-molecular-weight heparin (LMWH) indicated in the treatment of Guillain-Barre syndrome (GBS)?

Updated: May 04, 2018
  • Author: Michael T Andary, MD, MS; Chief Editor: Milton J Klein, DO, MBA  more...
  • Print
Answer

Subcutaneous unfractionated or low ̶ molecular-weight heparin (LMWH) and thromboguards are often used in the treatment of immobile patients to prevent lower-extremity deep venous thrombosis (DVT) and consequent pulmonary embolism (PE).


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!